Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy.

التفاصيل البيبلوغرافية
العنوان:	Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy.
المؤلفون:	Marshall M; Cleveland Clinic Children's Hospital, Cleveland, OH, USA., Malik A; University of Los Angeles Olive View, Los Angeles, CA, USA., Shah M; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Fish FA; Vanderbilt University, Nashville, TN, USA., Etheridge SP; University of Utah, Salt Lake City, UT, USA., Aziz PF; Cleveland Clinic Children's Hospital, Cleveland, OH, USA., Russell MW; C.S. Mott Children's Hospital, Ann Arbor, MI, USA., Tisma S; Nemours Children's Hospital, Wilmington, DE, USA., Pflaumer A; Royal Children's Hospital, University of Melbourne, Parkville, VIC, Australia., Sreeram N; University of Cologne, Cologne, Germany., Kubus P; Motol University, Prague, Czech Republic., Law IH; University of Iowa, Iowa City, IA, USA., Kantoch MJ; University of Alberta, Edmonton, AB, Canada., Kertesz NJ; Nationwide Children's Hospital, Columbus, OH, USA., Strieper M; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA., Erickson CC; Children's Specialty Physicians, University of Nebraska Medical Center, Omaha, NE, USA., Moore JP; University of California, Los Angeles, CA, USA., Nakano SJ; University of Colorado, Denver, CO, USA., Singh HR; Children's Hospital of San Antonio, Baylor College of Medicine, San Antonio, TX, USA., Chang P; Children's Mercy Hospital, Kansas City, MO, USA., Cohen M; Inova LJ Murphy Children's Hospital, Falls Church, VA, USA., Fournier A; University of Montreal, Montreal, QC, Canada., Ilina MV; Royal Children's Hospital, Glasgow, Scotland, UK., Zimmermann F; Advocate Hospital, Chicago, IL, USA., Horndasch M; German Heart Center, Munich, Germany., Li W; University of California, San Francisco, CA, USA., Batra AS; University of California, Irvine, CA, USA., Liberman L; Columbia University, New York, NY, USA., Hamilton R; Hospital for Sick Kids, Toronto, ON, Canada., Janson CM; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Sanatani S; University of British Columbia, Vancouver, BC, Canada., Zeltser I; University of Texas-Southwestern, Dallas, TX, USA., McDaniel G; University of Virginia, Charlottesville, VA, USA., Blaufox AD; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Garnreiter JM; Saint Louis University, Saint Louis, MO, USA., Balaji S; Oregon Health and Science University, 707 SW Gaines Street, Portland, OR, 97239, USA. balajis@ohsu.edu.
المصدر:	Pediatric cardiology [Pediatr Cardiol] 2023 Sep 09. Date of Electronic Publication: 2023 Sep 09.
Publication Model:	Ahead of Print
نوع المنشور:	Journal Article
اللغة:	English
بيانات الدورية:	Publisher: Springer Verlag Country of Publication: United States NLM ID: 8003849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1971 (Electronic) Linking ISSN: 01720643 NLM ISO Abbreviation: Pediatr Cardiol Subsets: MEDLINE
أسماء مطبوعة:	Publication: New York Ny : Springer Verlag Original Publication: [New York, Springer-Verlag]
مستخلص:	Hypertrophic cardiomyopathy (HCM), a common cardiomyopathy in children, is an important cause of morbidity and mortality. Early recognition and appropriate management are important. An electrocardiogram (ECG) is often used as a screening tool in children to detect heart disease. The ECG patterns in children with HCM are not well described.ECGs collected from an international cohort of children, and adolescents (≤ 21 years) with HCM were reviewed. 482 ECGs met inclusion criteria. Age ranged from 1 day to 21 years, median 13 years. Of the 482 ECGs, 57 (12%) were normal. The most common abnormalities noted were left ventricular hypertrophy (LVH) in 108/482 (22%) and biventricular hypertrophy (BVH) in 116/482 (24%) Of the patients with LVH/BVH (n = 224), 135 (60%) also had a strain pattern (LVH in 83, BVH in 52). Isolated strain pattern (in the absence of criteria for hypertrophy) was seen in 43/482 (9%). Isolated pathologic Q waves were seen in 71/482 (15%). Pediatric HCM, 88% have an abnormal ECG. The most common ECG abnormalities were LVH or BVH with or without strain. Strain pattern without hypertrophy and a pathologic Q wave were present in a significant proportion (24%) of patients. Thus, a significant number of children with HCM have ECG abnormalities that are not typical for "hypertrophy". The presence of the ECG abnormalities described above in a child should prompt further examination with an echocardiogram to rule out HCM. (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References:	Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J 35(39):2733–2779. https://doi.org/10.1093/eurheartj/ehu284. (PMID: 10.1093/eurheartj/ehu28425173338) Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P (2020) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 142(25):e558–e631. https://doi.org/10.1161/CIR.0000000000000937. (PMID: 10.1161/CIR.000000000000093733215931) Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD (2014) Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12–25 years of age). J Am Coll Cardiol 64(14):1479–1514. https://doi.org/10.1016/j.jacc.2014.05.006. (PMID: 10.1016/j.jacc.2014.05.00625234655) Wexler RK, Elton T, Pleister A, Feldman D (2009) Cardiomyopathy: an overview. Am Fam Physician 79(9):778–84. (PMID: 201410972999879) Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS (2012) Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol 110(7):1027–1032. https://doi.org/10.1016/j.amjcard.2012.05.035. (PMID: 10.1016/j.amjcard.2012.05.03522809754) Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM Jr, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC, American Heart Association Council on Nutrition, Physical Activity, and Metabolism (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American heart association council on nutrition, physical activity, and metabolism: endorsed by the American college of cardiology foundation. Circulation 15(12):1643–455. https://doi.org/10.1161/CIRCULATIONAHA.107.181423. (PMID: 10.1161/CIRCULATIONAHA.107.181423) Savage DD, Seides SF, Clark CE, Henry WL, Maron BJ, Robinson FC, Epstein SE (1978) Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58(3 Pt 1):402–408. https://doi.org/10.1161/01.cir.58.3.402. (PMID: 10.1161/01.cir.58.3.402567104) Dipchand AI, McCrindle BW, Gow RM, Freedom RM, Hamilton RM (1999) Accuracy of surface electrocardiograms for differentiating children with hypertrophic cardiomyopathy from normal children. Am J Cardiol 83(4):628–30. https://doi.org/10.1016/s0002-9149(98)00933-3. (PMID: 10.1016/s0002-9149(98)00933-310073881) Saarel EV, Granger S, Kaltman JR, Minich LL, Tristani-Firouzi M, Kim JJ, Ash K, Tsao SS, Berul CI, Stephenson EA, Gamboa DG, Trachtenberg F, Fischbach P, Vetter VL, Czosek RJ, Johnson TR, Salerno JC, Cain NB, Pass RH, Zeltser I, Silver ES, Kovach JR, Alexander ME, Pediatric Heart Network Investigators* (2018) Electrocardiograms in healthy North American children in the digital age. Circ Arrhythm Electrophysiol. 7:e005808. https://doi.org/10.1161/CIRCEP.117.005808. (PMID: 10.1161/CIRCEP.117.005808) Davignon A, Rautaharju P, Boisselle E et al (1980) Normal ECG standards for infants and children. Pediatr Cardiol 1:123–131. https://doi.org/10.1007/BF02083144. (PMID: 10.1007/BF02083144) Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, Carrier L, Bonne G, Tesson F, Richard P, Hainque B, Schwartz K, Komajda M (1998) Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 19(9):1377–1382. https://doi.org/10.1053/euhj.1998.1049. (PMID: 10.1053/euhj.1998.10499792264) McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR (2009) Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol 54(3):229–233. https://doi.org/10.1016/j.jacc.2009.02.071. (PMID: 10.1016/j.jacc.2009.02.07119589435) Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP (2021) The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 27:zwab046. https://doi.org/10.1093/eurjpc/zwab046. (PMID: 10.1093/eurjpc/zwab046) Ostman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U (2005) Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15(6):632–642. https://doi.org/10.1017/S1047951105001824. (PMID: 10.1017/S104795110500182416297259) Ostman-Smith I, Wisten A, Nylander E, Bratt EL, Granelli Ad, Oulhaj A, Ljungström E (2010) Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy. Eur Heart J. 31(4):439–49. https://doi.org/10.1093/eurheartj/ehp443. (PMID: 10.1093/eurheartj/ehp44319897498) Balaji S, DiLorenzo MP, Fish FA, Etheridge SP, Aziz PF, Russell MW, Tisma S, Pflaumer A, Sreeram N, Kubus P, Law IH, Kantoch MJ, Kertesz NJ, Strieper M, Erickson CC, Moore JP, Nakano SJ, Singh HR, Chang P, Cohen M, Fournier A, Ilina MV, Smith RT, Zimmerman F, Horndasch M, Li W, Batra A, Liberman L, Hamilton R, Janson CM, Sanatani S, Zeltser I, McDaniel G, Blaufox AD, Garnreiter JM, Katcoff H, Shah M (2019) Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. Heart Rhythm 16(10):1462–1467. https://doi.org/10.1016/j.hrthm.2019.04.040. (PMID: 10.1016/j.hrthm.2019.04.04031026510) Thompson AJ, Cannon BC, Wackel PL, Horner JM, Ackerman MJ, O’Leary PW, Eidem BW, Johnson JN (2016) Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy. Br J Sports Med 50(2):105–110. https://doi.org/10.1136/bjsports-2015-094880. (PMID: 10.1136/bjsports-2015-09488026729893) Östman-Smith I (2014) Differential diagnosis between left ventricular hypertrophy and cardiomyopathy in childhood. J Electrocardiol. 47(5):661–8. https://doi.org/10.1016/j.jelectrocard.2014.07.002. (PMID: 10.1016/j.jelectrocard.2014.07.00225060129) Brothers MB, Oster ME, Ehrlich A, Strieper MJ, Mahle WT (2014) Novel electrocardiographic screening criterion for hypertrophic cardiomyopathy in children. Am J Cardiol 113(7):1246–1249. https://doi.org/10.1016/j.amjcard.2013.12.039. (PMID: 10.1016/j.amjcard.2013.12.03924513471) Drezner JA, Ackerman MJ, Anderson J, Ashley E, Asplund CA, Baggish AL, Börjesson M, Cannon BC, Corrado D, DiFiori JP, Fischbach P, Froelicher V, Harmon KG, Heidbuchel H, Marek J, Owens DS, Paul S, Pelliccia A, Prutkin JM, Salerno JC, Schmied CM, Sharma S, Stein R, Vetter VL, Wilson MG (2013) Electrocardiographic interpretation in athletes: the “Seattle criteria.” Br J Sports Med 47(3):122–124. https://doi.org/10.1136/bjsports-2012-092067. (PMID: 10.1136/bjsports-2012-09206723303758) Czosek RJ, Cnota JF, Knilans TK, Pratt J, Guerrier K, Anderson JB (2014) Relationship between echocardiographic LV mass and ECG based left ventricular voltages in an adolescent population: related or random? Pacing Clin Electrophysiol 37(9):1133–1140. https://doi.org/10.1111/pace.12416. (PMID: 10.1111/pace.1241624787455) Koga Y, Yamaga A, Hiyamuta K, Ikeda H, Toshima H (2004) Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol 15(12):1402–1408. https://doi.org/10.1046/j.1540-8167.2004.04314.x. (PMID: 10.1046/j.1540-8167.2004.04314.x15610287) Papavassiliu T, Flüchter S, Haghi D, Süselbeck T, Wolpert C, Dinter D, Kühl H, Borggrefe M (2007) Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 9(3):595–603. https://doi.org/10.1080/10976640600945465. (PMID: 10.1080/1097664060094546517365241) Sharma S, Drezner JA, Baggish A et al (2018) International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 39:1466–1480. (PMID: 10.1093/eurheartj/ehw63128329355) Konno T, Shimizu M, Ino H, Yamaguchi M, Terai H, Uchiyama K, Oe K, Mabuchi T, Kaneda T, Mabuchi H (2004) Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 25(3):246–251. https://doi.org/10.1016/j.ehj.2003.10.031. (PMID: 10.1016/j.ehj.2003.10.03114972426) Bent RE, Wheeler MT, Hadley D, Froelicher V, Ashley E, Perez MV (2015) Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients. J Electrocardiol 48(3):362–7. https://doi.org/10.1016/j.jelectrocard.2015.01.009. (PMID: 10.1016/j.jelectrocard.2015.01.00925732098) Zorzi A, Calore C, Vio R, Pelliccia A, Corrado D (2018) Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete’s heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria. Br J Sports Med 52(10):667–673. https://doi.org/10.1136/bjsports-2016-097438. (PMID: 10.1136/bjsports-2016-09743828701362) Maron BJ, Wolfson JK, Ciró E, Spirito P (1983) Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 51(1):189–194. https://doi.org/10.1016/s0002-9149(83)80034-4. (PMID: 10.1016/s0002-9149(83)80034-46217739) Lemery R, Kleinebenne A, Nihoyannopoulos P, Aber V, Alfonso F, McKenna WJ (1990) Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol 16(2):368–374. https://doi.org/10.1016/0735-1097(90)90587-f. (PMID: 10.1016/0735-1097(90)90587-f2373813) Sato T, Nakamura K, Yamanari H, Yoshinouchi T, Ohe T (1998) Relationship between electrocardiographic features and distribution of hypertrophy in patients with hypertrophic cardiomyopathy. Jpn Circ J 62(7):483–488. https://doi.org/10.1253/jcj.62.483. (PMID: 10.1253/jcj.62.4839707003) Conway JJ, Krystofiak J, Quirolgico K, Como B, Altobelli A, Putukian M (2022) Evaluation of a preparticipation cardiovascular screening program among 1,686 national collegiate athletic association division I athletes: comparison of the seattle, refined, and international electrocardiogram screening criteria. Clin J Sport Med 32(3):306–312. https://doi.org/10.1097/JSM.0000000000000858. (PMID: 10.1097/JSM.000000000000085832487874) Hyde N, Prutkin JM, Drezner JA (2019) Electrocardiogram interpretation in NCAA athletes: Comparison of the “Seattle” and “International” criteria. J Electrocardiol 56:81–84. https://doi.org/10.1016/j.jelectrocard.2019.07.001. (PMID: 10.1016/j.jelectrocard.2019.07.00131326858)
معلومات مُعتمدة:	Protocol #1651 Medtronic External Research Program
فهرسة مساهمة:	Keywords: Electrocardiogram; Hypertrophic cardiomyopathy; Left ventricular hypertrophy; Pediatric; Strain; Sudden death
تواريخ الأحداث:	Date Created: 20230908 Latest Revision: 20230908
رمز التحديث:	20230909
DOI:	10.1007/s00246-023-03252-4
PMID:	37684488
قاعدة البيانات:	MEDLINE

Find this article in full text from Springer Verlag.

Full Text Finder

الوصف
تدمد:	1432-1971
DOI:	10.1007/s00246-023-03252-4